PerkinElmer Inks Newborn Screening Pact with China | GenomeWeb

NEW YORK (GenomeWeb) – PerkinElmer announced Tuesday it has signed an agreement to serve as the exclusive collaborator with China's National Health and Family Planning Commission to create and implement a newborn screening training program focused on rural China.

Under the three-year agreement, PerkinElmer will provide its diagnostic tests and expertise to develop and roll out a program that will "substantially increase adoption and access to newborn screening in China," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.